Vanda Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	70.02	102.32	135.82	135.03	52.07	61.03
Short-Term Investments	223.73	272.33	252.44	331.83	380.74	306.71
Cash & Short-Term Investments	293.75	374.64	388.26	466.86	432.81	367.74
Cash Growth	-21.93%	-3.51%	-16.84%	7.87%	17.70%	17.82%
Receivables	50.54	47.1	34.16	33.51	32.47	30.04
Inventory	2.04	1.73	1.36	1.19	1.03	1.28
Prepaid Expenses	21.16	15.42	9.17	6.23	12	10.03
Restricted Cash	-	-	-	-	-	0.06
Other Current Assets	-	-	-	11.5	-	-
Total Current Assets	367.5	438.89	432.95	519.29	478.3	409.15
Property, Plant & Equipment	11.9	12.68	9.14	10.97	12.39	14.6
Other Intangible Assets	108.84	114.1	121.37	18.57	20.08	21.56
Long-Term Deferred Tax Assets	103.07	81.44	75	74.04	74.88	81.52
Other Long-Term Assets	9.83	9.1	9.99	11.38	8.15	6.64
Total Assets	601.14	656.2	648.44	634.25	593.79	533.46
Accounts Payable	3.14	3.5	7.15	12.69	0.93	1.05
Accrued Expenses	39.79	31.32	28.92	30.53	31.2	27.99
Current Portion of Leases	4.69	4.27	2.4	2.33	2.31	2.12
Other Current Liabilities	70.25	60.9	49.24	45.89	39.98	34.78
Total Current Liabilities	117.87	99.98	87.7	91.44	74.42	65.94
Long-Term Leases	6.23	8.09	7.01	8.81	10.06	11.5
Other Long-Term Liabilities	11.04	9.59	8.83	6.8	4.39	2.76
Total Liabilities	135.14	117.66	103.53	107.05	88.86	80.19
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	718.98	712.71	700.27	686.24	669.22	650.3
Retained Earnings	-253.58	-174.29	-155.39	-157.9	-164.18	-197.33
Comprehensive Income & Other	0.54	0.07	-0.03	-1.19	-0.18	0.24
Shareholders' Equity	466	538.55	544.91	527.2	504.93	453.27
Total Liabilities & Equity	601.14	656.2	648.44	634.25	593.79	533.46
Total Debt	10.92	12.36	9.4	11.14	12.37	13.61
Net Cash (Debt)	282.84	362.28	378.86	455.72	420.45	354.13
Net Cash Growth	-23.21%	-4.38%	-16.86%	8.39%	18.73%	19.02%
Net Cash Per Share	4.82	6.23	6.58	8.00	7.39	6.42
Filing Date Shares Outstanding	59.1	58.32	57.54	56.79	55.91	54.88
Total Common Shares Outstanding	59.1	58.31	57.53	56.78	55.9	54.87
Working Capital	249.63	338.91	345.25	427.86	403.88	343.21
Book Value Per Share	7.89	9.24	9.47	9.28	9.03	8.26
Tangible Book Value	357.16	424.45	423.54	508.63	484.85	431.71
Tangible Book Value Per Share	6.04	7.28	7.36	8.96	8.67	7.87
Machinery	-	8.23	7.78	7.58	7.03	6.71
Leasehold Improvements	-	5.47	5.44	5.42	5.46	5.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.